- GlobeNewswire•6 days ago
Pluristem Reaches Milestone of 100 Granted Patents, Including Coverage of Leading Indications in Major Markets
In addition, Pluristem has over 110 pending patent applications. The patents portfolio covers over 30 different innovations across major markets. HAIFA, Israel, April 19, 2017-- Pluristem Therapeutics ...
- Zacks•18 days ago
As of late, it has definitely been a great time to be an investor in Pluristem Therapeutics Inc. (PSTI).
- Accesswire•20 days ago
Onconova Therapeutics and Pluristem Therapeutics Surge as Candidate Drugs Move Closer to Final Approval
NEW YORK, NY / ACCESSWIRE / April 5, 2017 / Onconova scored a 2-for-1 with its FDA candidate drug trials and Pluristem is on the cusp of their drug potentially having a broad military and national application. ...
PSTI : Summary for Pluristem Therapeutics, Inc. - Yahoo Finance
Pluristem Therapeutics Inc. (PSTI)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||1.15 x 3000|
|Day's Range||1.42 - 1.47|
|52 Week Range||1.04 - 1.85|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-4.43|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|